On May 22, gelonghui – Peijia medical-b (09996. HK) announced that on May 20, 2022, the group received the approval of the registration application of fastunnel delivery balloon dilation catheter (formerly known as newaytm balloon microcatheter) from the State Drug Administration, making it the 13th Neurointerventional product approved by the State Drug Administration.
Fastunnel delivery balloon dilation catheter is a new product developed by gaqi biology Co., Ltd. (a wholly-owned subsidiary of the company) for the treatment of intracranial atherosclerotic stenosis. As the first new instrument in China that can be used for balloon dilatation and stent delivery, its original “zero exchange” technology opens a new era in the treatment of intracranial atherosclerotic stenosis. Fastunnel delivery balloon dilation catheter adopts the integrated design of “balloon + microcatheter”, which reduces instrument exchange and improves surgical safety; The balloon is made of PEBAX semi compliant material, which can realize stable forming and safe expansion; It has two delivery lumen designs of 0.017 inch and 0.021 inch, which can be compatible with intracranial stent system; The whole process of the product adopts stainless steel reinforced structure, which can improve the traceability and is easy to transport intracranial stents; The length of its conveying system reaches 150cm, which is more compatible with intermediate conduits of 135cm and below.
Intracranial atherosclerotic stenosis is one of the most common causes of ischemic stroke in China. It has the characteristics of high incidence rate and high recurrence rate. In the process of intravascular interventional treatment of intracranial atherosclerotic stenosis, if there are more exchange operations during operation, it will lead to more complications such as vascular rupture, intracranial hemorrhage and vascular dissection. The innovative design of fastunnel delivery balloon dilation catheter closely meets the clinical needs, which can greatly simplify the operation steps, reduce the operation risk, improve the operation safety and reduce the surgical complications.
So far, for intracranial atherosclerotic stenosis, gagi biological product series has covered sacspeed balloon dilation catheter, fastunnel delivery balloon dilation catheter, Tethys intermediate guide catheter, presgo micro guide wire and presgo micro catheter. Jiaqi biology will continue to enrich the product layout in the field of ischemic stroke, continue to help the construction of China stroke center and promote the treatment of patients with ischemic stroke.
